South Korea

South Korean FDA Approval For Green Cross’ Neulapeg® South Korean FDA Approval For Green Cross’ Neulapeg®
  • August 27th, 2014
  • Green Cross receives regulatory approval for its once-per-cycle dose neutropenia drug, Neulapeg®.

» Read More...
Featured Research »
How Neurons Fire During Absence Seizures

How Neurons Fire During Absence Seizures

A study in mice questions the role of burst firing neurons in absence seizures and could lead to the development of new modes of treatment.

Health & Medicine »
Instant Noodles Associated With Cardiovascular Disease

Instant Noodles Associated With Cardiovascular Disease

A study of over 10,000 South Koreans shows that eating instant noodles two or more times a week is associated with cardiovascular disease, but only for women.

Academia »
Korean Engineer To Lead The Association For Information Systems

Korean Engineer To Lead The Association For Information Systems

Professor Lee Jae Kyu will serve as president of the professional association for information systems scientists, AIS.

Tech & Pharma »
South Korean FDA Approval For Green Cross’ Neulapeg®

South Korean FDA Approval For Green Cross’ Neulapeg®

Green Cross receives regulatory approval for its once-per-cycle dose neutropenia drug, Neulapeg®.

Editorials »
The Language Of Science Education: Between Two Trends

The Language Of Science Education: Between Two Trends

Saleh Al-Shair asks if science should be taught in native languages or in the global language of scientific research.